Daiichi gets SEBI, FIPB okay for Ranbaxy open offer

Japanese drug maker Daiichi Sankyo on Monday received approvals from the market regulator SEBI and Foreign Investment Promotion Board for the acquisition of 34.8 per cent stake in the Indian drug major Ranbaxy.

Related Videos